Quantcast
Home / Verdicts & Settlements / Shareholder uprising against PPD merger quelled by settlement (access required)

Shareholder uprising against PPD merger quelled by settlement (access required)

But not all investors are happy with agreement which allows $3.9 billion deal to proceed

Despite objections from one institutional shareholder, the North Carolina Business Court has approved the settlement of a class action against Wilmington-based clinical research company Pharmaceutical Product Development Inc. and two private equity firms.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>

 

Scroll To Top